Cannabigerol (CBG), decarboxylated CBGA, is a non-psychoactive cannabinoid. It is one of the many chemical compounds in the plant but is considered a minor cannabinoid since most CBGA is converted to THCA or CBDA. 

CBG is believed to interact with the body's endocannabinoid system, which regulates various physiological processes, such as mood, appetite, sleep, and pain perception. Research suggests that CBG may have various potential health benefits, including pain relief, anti-inflammation, anti-depressive, neuroprotective, and anti-cancer. 

While CBG is still being studied, it is thought to have the potential to be a therapeutic agent for many conditions.